As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – Regulation (EU) 2024/1689 of the European Parliament and of the Council of...

The purpose of this Regulation is to improve the functioning of the internal market by laying down a uniform legal framework in particular for...
As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – Regulation (EU) 2024/1860 of the European Parliament and of the Council of...

Regulations (EU) 2017/745 (3) and (EU) 2017/746 (4) of the European Parliament and of the Council establish a regulatory framework to ensure the smooth functioning of the internal market...

Europe – MDCG 2020-16 Rev.3 – Guidance on Classification Rules for in vitro Diagnostic...

This guidance, relating to the application of Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) addresses the classification of in vitro diagnostic...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – Medical devices: UK approved bodies

Approved bodies under Medical Devices Regulations 2002 (SI 2002 No 618, as amended) (UK MDR 2002) for medical devices...

Europe – MDCG 2021-5 Rev. 1 : Guidance on standardisation for medical devices

The EU legislative framework on medical devices currently consists of two Regulations adopted and entered into force in 2017: • Regulation (EU) 2017/745 on medical...

Europe – MDCG 2024-10 Clinical evaluation of orphan medical devices

The level of clinical evidence that is required to place medical devices on the market has been increased by the MDR, including an increased...
La Suisse valide l'utilisation du cannabis à des fins médicales

Switzerland – Swissmedic prepares medtech industry for activation of medical devices database module

The first module of the swissdamed medical devices database goes online in August Since the MRA with the EU has not been updated, Swissmedic does...

Europe – Health Technology Assessment : Guidance on reporting requirements for multiplicity issues and...

This guidance describes how to deal in practice with multiplicity issues and complementary analyses (like specific subgroup analyses, specific post hoc analyses and sensitivity analyses)...
As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – Health Technology Assessment : Guidance on outcomes for joint clinical assessments

Clinical outcome assessments (COAs), used in clinical studies (whether they are interventional (also called experimental), or observational), are a key component of health technology...
Opinion On Allergy Alert Test (AAT) as a proof-of-concept study

Europe – Phthalates in certain medical devices: updated SCHEER guidelines published

Today, following a request from the European Commission, the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) provided the update of their guidelines on...

NOS PROCHAINES FORMATIONS